4-Methylpropiophenone CAS: 5337-93-9

CAS NO: 5337-93-9
4-Methylpropiophenone
Chemical Name: 4'-Methylpropiophenone
Molecular Formula: C10H12O
Formula Weight: 148.2
CAS No.: 5337-93-9
Description Review
Description

4-Methylpropiophenone, also known as 4-methyl-α-propylbenzeneacetone or 4-MePPh, is an organic compound with the molecular formula C10H12O and a molecular weight of 148.21 g/mol. It is classified as a ketone and has a pale yellow color with a fruity odor. The CAS number for this compound is 5337-93-9.

Top Ten Keywords and Synonyms

  1. Mephedrone precursor
  2. PMA/PMMA precursor
  3. Chemical intermediate
  4. Drug synthesis
  5. MDMA precursor
  6. Benzodioxole precursor
  7. Cathinone precursor
  8. N-Methylamphetamine (NMA) precursor
  9. Methcathinone precursor
  10. 4-MePPh

Health Benefits of 4-Methylpropiophenone There are no known health benefits of 4-methylpropiophenone. This compound is not intended for any medicinal purposes and is only used in chemical research and synthesis.

Potential Effects of 4-Methylpropiophenone 4-methylpropiophenone is primarily used as a precursor in the synthesis of other compounds such as cathinone, methcathinone, mephedrone, and MDMA. It is also used as a precursor in the synthesis of PMA and PMMA, which are highly toxic substances with potentially lethal effects.

Product Mechanism As a chemical intermediate, 4-methylpropiophenone is used to synthesize other compounds through various chemical reactions. These reactions typically involve the use of reagents such as acids, bases, and solvents to modify the structure of the compound and produce the desired product.

Safety 4-methylpropiophenone is a hazardous substance and should be handled with caution. It may cause skin and eye irritation upon contact and can be harmful if ingested or inhaled. It is also flammable and can pose a fire hazard if exposed to heat or flame. Proper handling and storage procedures should be followed when working with this compound.

Side Effects There are no reported side effects associated with the use of 4-methylpropiophenone, as it is not intended for human consumption. However, exposure to this compound may cause irritation, headaches, nausea, and dizziness.

Dosing Information There is no recommended dosage for 4-methylpropiophenone, as it is not intended for human consumption. It should only be used in chemical research and synthetic applications by trained professionals following proper safety protocols.

Conclusion In conclusion, 4-methylpropiophenone is a chemical intermediate used in the synthesis of various compounds such as cathinone, methcathinone, mephedrone, and MDMA. It is not intended for human consumption and should only be handled by trained professionals following proper safety protocols. Although it has no known health benefits, it plays a critical role in the development of many pharmaceuticals and other chemicals.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code